Skip to content
10-Q

Quarterly Report

ImageneBio, Inc. IMA

0001193125-26-212073

← back to feed
Filed
May 7, 2026 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2026 · Apr 30, 2026 11.28M sh
Shares Diluted Q1 2026 · Mar 31, 2026 11.21M sh
Shares Diluted restated Q1 2026 · Mar 31, 2025 2.4M sh
Operating Cash Flow Q1 2026 · Mar 31, 2026 −$14.8M
Operating Cash Flow restated Q1 2026 · Mar 31, 2025 −$7.23M
Cash And Equivalents Q1 2026 · Mar 31, 2026 $76.05M
Cash And Equivalents Q1 2026 · Dec 31, 2025 $94.53M
Stockholders Equity Q1 2026 · Mar 31, 2026 $123.33M
Stockholders Equity Q1 2026 · Dec 31, 2025 $133.14M
Stockholders Equity restated Q1 2026 · Mar 31, 2025 −$169.6M
Stockholders Equity restated Q1 2026 · Dec 31, 2024 −$160.57M
Current Liabilities Q1 2026 · Mar 31, 2026 $6.63M
Current Liabilities Q1 2026 · Dec 31, 2025 $11.23M
Total Liabilities Q1 2026 · Mar 31, 2026 $13.36M
Total Liabilities Q1 2026 · Dec 31, 2025 $19.84M
Current Assets Q1 2026 · Mar 31, 2026 $122.01M
Current Assets Q1 2026 · Dec 31, 2025 $140.29M
Total Assets Q1 2026 · Mar 31, 2026 $136.68M
Total Assets Q1 2026 · Dec 31, 2025 $152.98M
Eps Diluted Q1 2026 · Mar 31, 2026 −$0.95
Eps Diluted restated Q1 2026 · Mar 31, 2025 −$3.80
Eps Basic Q1 2026 · Mar 31, 2026 −$0.95
Eps Basic restated Q1 2026 · Mar 31, 2025 −$3.80
Sga Expense Q1 2026 · Mar 31, 2026 $6.12M
Sga Expense restated Q1 2026 · Mar 31, 2025 $2.76M
Rd Expense Q1 2026 · Mar 31, 2026 $5.96M
Rd Expense restated Q1 2026 · Mar 31, 2025 $4.04M
Net Income Q1 2026 · Mar 31, 2026 −$10.62M
Net Income restated Q1 2026 · Mar 31, 2025 −$6.08M
Operating Income Q1 2026 · Mar 31, 2026 −$12.08M
Operating Income restated Q1 2026 · Mar 31, 2025 −$6M
Revenue Q1 2026 · Mar 31, 2025 $800K